Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METROPHOLYS: Metronomic cyclophosphamide vs doxorubicin in elderly advanced soft tissue sarcoma
2018-001075-20Phase 3Terminated
- Sponsor
- Istituto Oncologico Veneto
- Start
- Nov 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, doxorubicin in soft tissue sarcoma (STS), sponsored by Istituto Oncologico Veneto. Started Nov 2020; status: terminated.
02
Drugs
cyclophosphamidedoxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2018-001075-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001075-20.